137 related articles for article (PubMed ID: 28381174)
1. Distinct prognostic values of YAP1 in gastric cancer.
Yu L; Gao C; Feng B; Wang L; Tian X; Wang H; Ma D
Tumour Biol; 2017 Apr; 39(4):1010428317695926. PubMed ID: 28381174
[TBL] [Abstract][Full Text] [Related]
2. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma.
Li P; Sun D; Li X; He Y; Li W; Zhao J; Wang Y; Wang H; Xin Y
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1765-73. PubMed ID: 27325246
[TBL] [Abstract][Full Text] [Related]
5. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
6. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
7. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
8. Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer.
Song M; Cheong JH; Kim H; Noh SH; Kim H
Anticancer Res; 2012 Sep; 32(9):3827-34. PubMed ID: 22993325
[TBL] [Abstract][Full Text] [Related]
9. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
11. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
[TBL] [Abstract][Full Text] [Related]
12. YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.
Cui ZL; Han FF; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
Int J Immunopathol Pharmacol; 2012; 25(4):989-1001. PubMed ID: 23298489
[TBL] [Abstract][Full Text] [Related]
13. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
14. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.
Hong SA; Jang SH; Oh MH; Kim SJ; Kang JH; Hong SH
Pathol Res Pract; 2018 Mar; 214(3):335-342. PubMed ID: 29487002
[TBL] [Abstract][Full Text] [Related]
16. Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop.
Huang S; Cao Y; Guo H; Yao Y; Li L; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2020 Oct; 24(19):11133-11145. PubMed ID: 32827244
[TBL] [Abstract][Full Text] [Related]
17. Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
Jeong W; Kim SB; Sohn BH; Park YY; Park ES; Kim SC; Kim SS; Johnson RL; Birrer M; Bowtell DSL; Mills GB; Sood A; Lee JS
Anticancer Res; 2014 Feb; 34(2):811-817. PubMed ID: 24511017
[TBL] [Abstract][Full Text] [Related]
18. Significance of aquaporins' expression in the prognosis of gastric cancer.
Thapa S; Chetry M; Huang K; Peng Y; Wang J; Wang J; Zhou Y; Shen Y; Xue Y; Ji K
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29678898
[TBL] [Abstract][Full Text] [Related]
19. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling.
Tang DE; Dai Y; Lin LW; Xu Y; Liu DZ; Hong XP; Jiang HW; Xu SH
Cancer Sci; 2019 Oct; 110(10):3145-3156. PubMed ID: 31393050
[TBL] [Abstract][Full Text] [Related]
20. The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.
Li S; Yu Z; Chen SS; Li F; Lei CY; Chen XX; Bao JM; Luo Y; Lin GZ; Pang SY; Tan WL
Urol Oncol; 2015 Oct; 33(10):427.e1-10. PubMed ID: 26163939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
